Correlation Between Park Electrochemical and Summit Therapeutics
Can any of the company-specific risk be diversified away by investing in both Park Electrochemical and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Park Electrochemical and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Park Electrochemical and Summit Therapeutics PLC, you can compare the effects of market volatilities on Park Electrochemical and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Park Electrochemical with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Park Electrochemical and Summit Therapeutics.
Diversification Opportunities for Park Electrochemical and Summit Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Park and Summit is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Park Electrochemical and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Park Electrochemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Park Electrochemical are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Park Electrochemical i.e., Park Electrochemical and Summit Therapeutics go up and down completely randomly.
Pair Corralation between Park Electrochemical and Summit Therapeutics
Considering the 90-day investment horizon Park Electrochemical is expected to generate 10.54 times less return on investment than Summit Therapeutics. But when comparing it to its historical volatility, Park Electrochemical is 2.88 times less risky than Summit Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1,747 in Summit Therapeutics PLC on November 5, 2024 and sell it today you would earn a total of 251.00 from holding Summit Therapeutics PLC or generate 14.37% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Park Electrochemical vs. Summit Therapeutics PLC
Performance |
| Timeline |
| Park Electrochemical |
| Summit Therapeutics PLC |
Park Electrochemical and Summit Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Park Electrochemical and Summit Therapeutics
The main advantage of trading using opposite Park Electrochemical and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Park Electrochemical position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.| Park Electrochemical vs. Innovative Solutions and | Park Electrochemical vs. VSE Corporation | Park Electrochemical vs. Curtiss Wright | Park Electrochemical vs. Ducommun Incorporated |
| Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |